GEn1E Lifesciences
PrivateLast Round
Grant
Oct 24, 2023
Total Funding Raised
$4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GEn1E Lifesciences is a biotechnology company that accelerates the development of next-generation immunomodulatory therapies for rare and inflammatory diseases through an innovative drug development platform that leverages artificial intelligence to create novel therapeutics rapidly.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GEn1E Lifesciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
GEn1E Lifesciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2023 | ||||
| VC Round | Dec 6, 2022 | ||||
| Seed | Mar 31, 2020 | ||||
| Seed | Aug 21, 2019 |
GEn1E Lifesciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed |
| Khosla Ventures | Seed, VC Round |
| Gaingels | VC Round |
| Inflect Health | Seed, VC Round |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Clear Ventures | Seed, VC Round |
| Y Combinator | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 65% MoM.
GEn1E Lifesciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GEn1E Lifesciences's valuation, stock price, and market status.